Acs Dobfar Overview

  • Year Founded
  • 1973

Year Founded

  • Status
  • Private

  • Employees
  • 1,065

Employees

  • Latest Deal Type
  • Debt

  • Latest Deal Amount
  • $170M

Acs Dobfar General Information

Description

Manufacturer of pharmaceutical products for the antibiotic sector intended to offer stakeholders cutting-edge anti-infective products. The company's products include beta-lactam and non-beta-lactam anti-infectives, cephalosporins, carbapenems and penicillins, enabling pharmaceutical companies to get cost-effective and affordable medicines.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Debt Financed
Corporate Office
  • Viale Addetta, 4/12
  • 20067 Tribiano(Milan)
  • Italy
+39 02
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Viale Addetta, 4/12
  • 20067 Tribiano(Milan)
  • Italy
+39 02

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Acs Dobfar Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Debt - General 15-Mar-2019 $170M Completed Generating Revenue
3. Debt Refinancing 01-Sep-2016 Completed Generating Revenue
2. Debt - General 01-Jan-2014 $82.3M $135M Completed Generating Revenue
1. Debt - General 01-Jan-2011 $52.9M $52.9M Completed Generating Revenue
To view Acs Dobfar’s complete valuation and funding history, request access »

Acs Dobfar Patents

Acs Dobfar Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10214543-B2 Synthesis of cephalosporin compounds Active 30-Dec-2014
US-20180170949-A1 Synthesis of cephalosporin compounds Active 30-Dec-2014
US-20170129906-A1 Reactions of thiadiazolyl-oximinoacetic acid derivative compounds Active 20-Jun-2014
US-9695196-B2 Reactions of thiadiazolyl-oximinoacetic acid derivative compounds Active 20-Jun-2014
US-20160000921-A1 Ceftolozane antibiotic compositions Active 15-Mar-2013 A61K47/02
To view Acs Dobfar’s complete patent history, request access »

Acs Dobfar Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Acs Dobfar Acquisitions (2)

Acs Dobfar’s most recent deal was a Merger/Acquisition with Istituto Biochimico Italiano Giovanni Lorenzini. The deal was made on 22-Jul-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Istituto Biochimico Italiano Giovanni Lorenzini 22-Jul-2026 Merger/Acquisition Other Pharmaceuticals and Biotechnology
GlaxoSmithKline (Antibiotic Production Business In Verona, Italy) 01-Feb-2020 Merger/Acquisition Pharmaceuticals
To view Acs Dobfar’s complete acquisitions history, request access »

Acs Dobfar Affiliates

Subsidiaries (3)

Name Industry Location Year Founded
Ibigen - Societa A Responsabilita Limitata Aprilia, Italy 1980
La.Chi. Lavorazioni Chimiche San Donato Milanese, Italy 1977
Istituto Biochimico Italiano Giovanni Lorenzini Aprilia, Italy 1918

Acs Dobfar FAQs

  • When was Acs Dobfar founded?

    Acs Dobfar was founded in 1973.

  • Where is Acs Dobfar headquartered?

    Acs Dobfar is headquartered in Tribiano, Italy.

  • What is the size of Acs Dobfar?

    Acs Dobfar has 1,065 total employees.

  • What industry is Acs Dobfar in?

    Acs Dobfar’s primary industry is Pharmaceuticals.

  • Is Acs Dobfar a private or public company?

    Acs Dobfar is a Private company.

  • What is Acs Dobfar’s current revenue?

    The current revenue for Acs Dobfar is .

  • How much funding has Acs Dobfar raised over time?

    Acs Dobfar has raised $501M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process